New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cue Biopharma, Inc.
CUE
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

95M

Biotechnology

Next Earning date - 14 Nov 2024

95M

Biotechnology

Next Earning date - 14 Nov 2024

1.57USD
Shape-0.03 ( -1.88%)
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

-46%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

52%

Quote Panel

Shape
Updated October 24, 2024
1W 29.75 % 1M 230.46 % 3M 123.23 % 1Y -16.04 %

Key Metrics

Shape
  • Market Cap

    94.53M


  • Shares Outstanding

    60.21M


  • Share in Float

    59.65M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    1.57


  • Average Volume

    681614


  • Beta

    1.958


  • Range

    0.45-3.249


  • Industry

    Biotechnology


  • Website

    https://www.cuebiopharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

11.39x

P/S Ratio

3.64x

P/B Ratio

0.4

Debt/Equity

-566.0%

Net Margin

$-1.0

EPS

How CUE compares to sector?

P/E Ratio

Relative Strength

Shape

CUE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10M

Shape280%

2025-Revenue

$0.64

Shape-218%

2025-EPS

$10M

Shape-6%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

initialise

Previous: Not converted

2022-11-20

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.31
vs -0.41

Q4.22

arrow
arrow

N/A

-0.37
vs -0.26

Q1.23

arrow
arrow

N/A

-0.29
vs -0.44

Q2.23

arrow
arrow

N/A

-0.29
vs -0.37

Q3.23

arrow
arrow

N/A

-0.24
vs -0.31

Q4.23

arrow
arrow

N/A

-0.37
vs -0.37

Q1.24

arrow
arrow

N/A

-0.25
vs -0.29

Q2.24

arrow
arrow

N/A

-0.20
vs -0.29

Q3.24

arrow
arrow

N/A

-0.18
vs -0.24

Q4.24

arrow
arrow

N/A

-0.11
vs -0.37

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-97%

68K  vs 2.4M

Q4.22

arrow
arrow

-98%

151.2K  vs 8.3M

Q1.23

arrow
arrow

-81%

187K  vs 1M

Q2.23

arrow
arrow

+5215%

1.4M  vs 26K

Q3.23

arrow
arrow

+2988%

2.1M  vs 68K

Q4.23

arrow
arrow

+1104%

1.8M  vs 151.2K

Q1.24

arrow
arrow

+818%

1.7M  vs 187K

Q2.24

arrow
arrow

+92%

2.7M  vs 1.4M

Q3.24

arrow
arrow

-28%

1.5M  vs 2.1M

Q4.24

arrow
arrow

+5%

1.9M  vs 1.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-21%

-0.21
vs -0.22

Q4.22

arrow
arrow

-22%

-0.22
vs -0.21

Q1.23

arrow
arrow

-24%

-0.24
vs -0.22

Q2.23

arrow
arrow

-29%

-0.29
vs -0.24

Q3.23

arrow
arrow

-26%

-0.26
vs -0.29

Q4.23

arrow
arrow

-36%

-0.36
vs -0.26

Q1.24

arrow
arrow

-41%

-0.41
vs -0.36

Q2.24

arrow
arrow

-47%

-0.47
vs -0.41

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

64

64
vs 77

-17%

Q4.22

arrow
arrow

63

63
vs 64

-2%

Q1.23

arrow
arrow

64

64
vs 63

2%

Q2.23

arrow
arrow

80

80
vs 64

25%

Q3.23

arrow
arrow

79

79
vs 80

-1%

Q4.23

arrow
arrow

85

85
vs 79

8%

Q1.24

arrow
arrow

79

79
vs 85

-7%

Q2.24

arrow
arrow

75

75
vs 79

-5%

Earnings Growth

Latest News